This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
is at an all time high, with 942k cardiovasculardisease-related deaths in 2022, up by 10k from 2021. as of 2020) have some form of CVD (comprising CHD, HF, stroke, and hypertension). Excluding hypertension (CHD, HF, and stroke only), just 9.9% From 2017 to 2020, adult obesity prevalence in the U.S.
The robustness of the results was verified by subgroup and sensitivity analyses.ResultsA cohort of 11,556 people with a diagnosis of hypertension was included in this study.
Objectives To determine the clinical profile, according to the history of hypertension, the risk of developing hypertension, current antihypertensive treatment and BP control rates in patients with hypertension from the IBERICAN cohort. This analysis shows the baseline clinical characteristics of patients with hypertension.
Atherosclerosisa key driver of cardiovasculardisease (CVD)continues to be a significant global health issue. The Global Burden of Disease data (2023) highlights a grim reality: while high-income countries have seen some success in managing CVD, LMICs now account for most CVD-related deaths.
In today’s society, the prevalence of obesity has become a significant concern. have obesity, and this rate has increased by more than 10 percentage points in the past two decades. Understanding the prevalence of obesity is crucial in comprehending why events like Healthy Weight Week are essential. of adults in the U.S.
Driven by common pathophysiologic underpinnings (eg, inflammation and neurohormonal dysregulation), cardiovasculardisease, cognitive impairment, and frailty also share the following risk factors: hypertension, diabetes, obesity, sedentary behavior, and tobacco use.
We projected through 2050, overall and by age and race and ethnicity, accounting for changes in disease prevalence and demographics.RESULTS:We estimate that among adults, prevalence of hypertension will increase from 51.2% to 26.8%) and obesity (43.1% Prevalences of coronary disease (7.8% in 2020 to 61.0% Diabetes (16.3%
Obesity is a multifaceted disease that is directly and indirectly implicated in atherosclerotic cardiovasculardisease (CVD), heart failure (HF), atrial fibrillation (AF), and multiple CVD risk factors, including dyslipidemia, hypertension, type 2 diabetes mellitus (DM), and sleep disorders.
Among hypertensive cohorts across different nations, the relationship between the triglyceride-glucose index (TyG) and its conjunction with obesity metrics in relation to cardiovasculardisease (CVD) incidence.
A new JAMA study revealed that a shocking 90% of US adults are at risk of developing cardiovascular-kidney-metabolic (CKM) syndrome, underscoring the need for preventative action before we face a wave of CKM-related heart disease. Stage 4 (heart disease, with or without kidney disease) – 9.2% in Whites).
A projected rise in heart disease and stroke – along with several key risk factors, including high blood pressure and obesity – is likely to triple related costs to $1.8 population could be affected by cardiovasculardisease within the next 30 years, according to two new science reports. and Susan F. to 61% of the U.S.
Cardiovasculardisease (CVD) is the leading cause of death worldwide, accounting for over one-third of all deaths in Singapore. Furthermore, other major risk factors, such as diabetes mellitus, hypertension, elevated low-density lipoprotein levels, and obesity, are steadily rising. billion USD (11.5 billion SGD).
Obesity, a major risk factor for cardiovasculardisease (CVD), is associated with hypertension and vascular dysfunction. Perivascular adipose tissue (PVAT), a metabolically active tissue surrounding blood vess.
Multivariable logistic models evaluated associations of RARs with prevalent CVD, hypertension, obesity, and central adiposity. A more active wake period was associated with 19% to 72% lower CVD, hypertension, obesity, and central adiposity odds.
Pre-eclampsia and heart failure have common risk factors, including hypertension, obesity and diabetes. Multiple logistic regression analysis was used to evaluate the impact of heart failure on the risk of pre-eclampsia, with adjustment for established risk factors and other cardiovasculardiseases.
Can you please explain the concept of an obesity paradox? Salvatore Carbone, PhD: First, I’d like to point out that obesity is a major risk factor for cardiometabolic disease. 2, 3] This association is more pronounced for those with class I obesity, which is a body mass index (BMI) between 30-35 kg/m2.
Hypertension, Ahead of Print. Background:Hypertensive disorders of pregnancy are associated with cardiovasculardisease; however, patterns of blood pressure (BP) recovery are understudied. Pregnancy BPs were obtained during prenatal visits; postpartum BPs were prospectively obtained through home monitoring.
Recently, indisputable evidence has shown that the TyG index is strongly associated with cardiovasculardisease [CVD, including atherosclerosis, heart failure (HF), and hypertension] prognosis and mortality. Finally, we summarized the mechanism of the “obesity paradox.”
Don’t worry—you can still access the 19th Annual CMHC sessions through our On-Demand platform, which offers 14 CME credits across four comprehensive tracks: Cardiorenal Health: Stay up-to-date with the latest on therapies for resistant hypertension, chronic kidney disease markers, and cardiac risk assessment tools.
It’s well known that heart disease is the U.S.’s s top cause of death, and our rising CVD rates have been widely covered, but a look back on some of the biggest stories of 2024 suggests that cardiovasculardisease is about to become a much bigger problem. Hypertension Problems: Another JAMA study highlighted the U.S.’s
Practical, Future-Focused Education Cardiorenal and metabolic diseases, fueled by poor lifestyle choices and health conditions, lead to type 2 diabetes, cardiovasculardisease, and chronic kidney disease. Michos, MD, MHS, FACC, FAHA, FASE, FASPC ; famed hypertension expert Keith C.
Aims:Asian Americans experience disproportionate burdens of cardiovascular risk factors and cardiovasculardisease (CVD). However, the trends in cardiovascular risks in adults from different Asian ethnic backgrounds remain understudied. Asian Indian adults exhibited uptrends in overweight/obesity (AAPC: 1.1%,p<
Cardiovasculardisease (CVD) is the leading cause of pregnancy-related maternal death in the United States, driven by rising rates of hypertension, diabetes mellitus (DM), obesity, smoking, and advanced maternal age.
2 Most are balancing multiple comorbidities, such as obesity, diabetes, hypertension and chronic kidney disease (CKD). American Diabetes Association (Section 10: Cardiovasculardisease and risk management: standards of care in diabetes2024.). 4 Approximately 6.7 million adults in the U.S. Accessed March 10, 2025.
Circadian rhythms in blood pressure and heart rate, among other functions, are crucial for cardiovascular health and preventing cardiovasculardisease. This is supported by studies showing that ALAN exposure is associated with a range of conditions like cardiometabolic disease, obesity, and diabetes. Read more
Meanwhile, Metabolically healthy obesity (MHO) trends are understudied in association with stroke. Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024.
Dr. Pradeep Natarajan (United States of America) suggested that polygenic risk scores could play a larger role in identifying individuals at risk for cardiovasculardisease (CVD). Ultimately, there is an overlap between high-risk primary prevention for cardiovasculardisease (CVD) and secondary prevention.
Black History Month is a poignant backdrop to the alarming rise in obesity and type 2 diabetes, particularly among those of marginalized populations. This troubling trend has cemented the 100-year reign of cardiovasculardiseases (CVD) as the #1 killer in America.
Six multimorbidity patterns were identified, including 4 specific patterns: (1) pattern 1, cerebrovascular cluster (histories of cerebrovascular disease and hypertension); (2) pattern 2, traditional cardiovasculardisease risk factors cluster (histories of hyperlipidemia, obesity, anddiabetes, and family history of cardiovasculardisease and smoking); (..)
There is a clear relationship between sleep deprivation and the development of conditions like obesity, diabetes, and hypertension. Somers delves into the growing body of research connecting poor sleep with heightened cardiometabolic risk.
The European Society of Cardiology (ESC) Congress 2024 (August 30 – September 2, 2024) has wrapped up, delivering groundbreaking insights into cardiovasculardiseases and related conditions. New guidelines also: Classify “Elevated BP” between non-elevated BP and hypertension.
These diets, including vegan and vegetarian variations, have shown links to lower risks of ischemic heart disease ; reduced body weight and lowered ApoB levels ; and a decreased risk of all-cause mortality, cancer, and cardiovasculardisease.
The American Heart Association (AHA) Congress 2024 , held from November 1618, marked a pivotal moment in cardiovascular and metabolic health. As the AHA celebrates its 100th year, the conference reflected on a century of innovation while exploring the future of cardiovasculardisease prevention and management.
Changes in BCAA homeostasis have emerged as pivotal contributors in the pathophysiology of several cardiometabolic diseases, including type 2 diabetes, obesity, hypertension, atherosclerotic cardiovasculardisease, and heart failure.
Insufficient or interrupted sleep can affect blood pressure and increase the risk of heart attacks, stroke, diabetes, and other cardiovasculardiseases. High blood pressure and heart disease are related to insomnia. Hypertensive heart disease is brought on by persistently high blood pressure (greater than 120/80 mmHg).
For instance, a pediatric provider may be only interested in topics pertaining to childhood obesity. They could find resources and education focused on that condition within both the Obesity Management and Pediatrics hubs.
Cardiovasculardisease remains the leading cause of death worldwide, and it poses a significant threat to men’s health. While cardiovascular risk affects both genders, men often face unique challenges and factors that increase their susceptibility.
The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovasculardisease (CVD), the leading cause of death and disability in the United States.
He discussed therapeutic options not only for treating atherosclerosis but also for preventing cardiovasculardisease. Attendees dove into cutting-edge topics, including FDA updates, resistant hypertension, and cardiac biomarkers. “I Aronne, MD , discussed advances in obesity pharmacology, while Virend K.
An analysis of nearly 8,000 STEMI patients over 20 years found the majority of STEMI occur in individuals without prior cardiovasculardisease, and this prevalence is unchanged over time. said Michael Miedema, MD, MPH , director of the Nolan Family Center for Cardiovascular Health at MHIF and senior author of the research.
BackgroundAsian people in the United States have different sociodemographic and health‐related characteristics that might affect cardiovasculardisease (CVD) risk by ethnicity and birthplace. Journal of the American Heart Association, Ahead of Print. However, they are often studied as a monolithic group in health care research.
ET Main Tent (Hall B1) Effect of Gamification, Financial Incentives or Both Combined to Increase Physical Activity Among Patients with Elevated Risk For Major Adverse Cardiovascular Events. Clinical and Investigative Horizons (Session 410) Sunday, April 7 4:30 – 5:45 p.m.
BACKGROUND:The relationship between marijuana use and cardiovascular health remains uncertain, with several observational studies suggesting a potential association with increased adverse atherosclerotic cardiovasculardisease (ASCVD) outcomes. P=0.84), obesity (35.8% versus 18.8%,P=0.76; P=0.76; 79.8% versus 77.8%,P=0.75),
Risk factors for cardiovasculardisease Understanding the risk factors for cardiovasculardisease is crucial for maintaining optimal cardiovascular health. How to maintain a healthy cardiovascular system Maintaining a healthy cardiovascular system is vital for overall well-being and longevity.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content